Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813771 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chung-Hsin Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, National Taiwan Normal University, Taipei 106, Taiwan. Hauptthemen laut MEDLINE: Neurofilament Proteins, Biomarkers, Cognitive Dysfunction, Dog Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TTY BIOPHARM CO., LTD., SHIUN CHAO BIOPHARM CO., LTD., National Taiwan Normal University.
Abstract (Originalsprache)
The number of elderly dogs is increasing significantly worldwide, and many elderly dogs develop canine cognitive dysfunction syndrome (CCDS). CCDS is the canine analog of Alzheimer’s disease (AD) in humans. It is very important to develop techniques for detecting CDDS in dogs. Thus, we used the detection of neurofilament light chains (NfL) in plasma as a blood-based biomarker for the early diagnosis of canine Alzheimer’s disease using immunomagnetic reduction (IMR) technology by immobilizing NfL antibodies on magnetic nanoparticles. According to the 50-point CCDS rating scale, we divided 36 dogs into 15 with CCDS and 21 without the disease. The results of our IMR assay showed that the plasma NfL levels of dogs with CCDS were significantly increased compared to normal dogs (p < 0.01). By plasma biochemical analysis, we further confirmed that the liver and renal dysfunction biomarkers of dogs with CCDS were significantly elevated compared to normal dogs (p < 0.01–0.05). On the basis of our preliminary study, we propose that IMR technology could be an ideal biosensor for detecting plasma NfL for the early diagnosis of CCDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
- Zaixing Animal Hospital, Taipei 116, Taiwan.
- Department of Physiology, College of Medicine, National Taiwan University, Taipei 106, Taiwan.
- MagQu Co., Ltd., New Taipei City 112, Taiwan.
ORCID-Profile: Chung-Hsin Wu
Förderung
- TTY BIOPHARM CO., LTD.
- SHIUN CHAO BIOPHARM CO., LTD.
- National Taiwan Normal University
Zitieren
APA
Wu, C. H., Pan, X. S., Su, L. Y., & Yang, S. Y. (2023). Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813771
Vancouver
Wu CH, Pan XS, Su LY, Yang SY. Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813771
BibTeX
@article{Wu2023,
author = {Wu, Chung-Hsin and Pan, Xun-Sheng and Su, Li-Yu and Yang, Shieh-Yueh},
title = {Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813771}
}
EUVIMED